What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions-Reference-Cited by-同舟云学术

What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions

Published:2020-12-30 Issue:3 Volume:7 Page:e2-e3
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Gambardella Jessica¹²³,Santulli Gaetano¹²³^ORCID

Affiliation:

1. Department of Medicine, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA

2. Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA

3. Department of Advanced Biomedical Science, “Federico II” University, and International Translational Research and Medical Education Consortium (ITME), Via Sergio Pansini 5, 80131 Naples, Italy

Funder

American Heart Association

NIH

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/7/3/e2/38114331/pvaa145.pdf

Reference9 articles.

1. Therapy for early COVID-19: a critical need;Kim;JAMA,2020

2. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence;Sardu;J Clin Med,2020